New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...
News-Medical.Net on MSN
Research explores new solvent strategies to extend shelf life of injectable therapeutics
Kennesaw State University Assistant Professor of Chemistry and Biochemistry Mohammad Halim has received a three-year National ...
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
The FDA has approved a new type of medication to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare disease that causes extremely high triglycerides.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results